Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Harvard Bioscience buy Benchmark Co.

Start price
€2.60
10.03.23 / 50%
Target price
€3.77
10.03.24
Performance (%)
51.54%
End price
€3.94
11.03.24
Summary
This prediction ended on 11.03.24 with a price of €3.94. The BUY prediction by Benchmark_Co_ for Harvard Bioscience saw massive gains of 51.54%. Benchmark_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Harvard Bioscience -2.286% -2.286% -35.472%
iShares Core DAX® 4.015% 2.971% 16.492%
iShares Nasdaq 100 2.755% 0.503% 40.029%
iShares Nikkei 225® -0.826% -5.057% 14.566%
iShares S&P 500 2.330% 0.720% 30.194%

Comments by Benchmark_Co_ for this prediction

In the thread Harvard Bioscience diskutieren
Prediction Buy
Perf. (%) 51.54%
Target price 3.766
Change
Ends at 10.03.24

Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for HBIO provided by MarketBeat

In the thread Trading Harvard Bioscience
Prediction Buy
Perf. (%) 51.54%
Target price 3.766
Change
Ends at 10.03.24

Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten